A Complement-Mediated Rat Xenotransfusion Model of Platelet Refractoriness

A Complement-Mediated Rat Xenotransfusion Model of Platelet Refractoriness

Posted by Adam Awdish on

Innovative Grade US Origin Rat Sprague Dawley Complement Serum from Innovative Research was used in the following study:

 

A Complement-Mediated Rat Xenotransfusion Model of Platelet Refractoriness

Adrianne I. Enos, Pamela S. Hair, Neel K. Krishna, Kenji M. Cunnion

Molecular Immunology
May 30, 2020

Platelet refractoriness, or the failure of transfused platelets to increase a patient’s platelet count that results in continued thrombocytopenia, is a concerning medical issue that has an urgent need for a solution. This continued state of thrombocytopenia can increase the risk of spontaneous bleeding in the patient and can result in increased medical expenses due to the need for additional treatments and procedures.

The most common cause for platelet refractoriness is related to immune mechanisms, however some cases can stem from non-immune mechanisms such as intravascular coagulopathy and splenomegaly. Regarding immune mechanisms, the most common factor contributing to platelet refractoriness is alloimmunization, or the phenomenon where patients develop anti-platelet antibodies after receiving multiple platelet transfusions. Further, recent studies have shown that anti-HLA antibodies are able to activate the complement pathway that initiates membrane attacks on platelets, thus suggesting that the complement system plays some role in immune-related platelet refractoriness.

Current attempts to counter platelet refractoriness focus transfusing only HLA-matched platelets, however it is often difficult to find readily available donors. In this study, researchers observed complement-mediated killing of platelets ex vivo to better understand how the complement system affects platelet viability. The findings suggest that platelet viability is decreased by complement activation, however this can be reversed with complement inhibitor PA-dPEG24.

 

Related products available from Innovative Research also include:

Rat Sprague Dawley Plasma

Innovative Grade US Origin Mouse CD1 Whole Blood

Single Donor Human Serum Off The Clot

  • Tags: Animal Serum, Innovative Grade US Origin Rat Sprague Dawley Serum, Innovative Grade US Origin Rat Wistar Complement Serum

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Effect of Photo-Mediated Ultrasound Therapy on Nitric Oxide and Prostacyclin from Endothelial Cells
    Innovative Grade US Origin Monkey Rhesus Whole Blood from Innovative Research was used ...
    Read the Article
    A Very Long-Acting IL-15: Implications for the Immunotherapy of Cancer
    Innovative Grade US Origin Mouse C57BL6 Plasma from Innovative Research was used in the...
    Read the Article

    ← Older Post Newer Post →

    ×